← All diseases
Liver, kidneys and digestion
Fatty liver disease (MASH/NASH), advanced
Do you want to receive a message when there is new research about Liver Fat (MASH/NASH), advanced? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, a single sentence appears above each publication explaining what was studied — and you'll be notified as soon as new research on Liver Steatosis (MASH/NASH), Advanced is available. View what Premium costs.
Publications and studies (2544)
- Sex- and menopause-specific inverse associations between metabolic dysfunction-associated steatotic liver disease and serum lipoprotein(a) concentrations: evidence from SHIP and UK Biobank. (2026/07/12) ♡
- Association of Pro-Inflammatory Diets With Increased Risk of Metabolic Dysfunction-Associated Steatohepatitis: Evidence From a Prospective Cohort Study. (2026/07/12) ♡
- Dietary milk polar lipids ameliorate hepatic lipid accumulation through coordinated regulation of Wnt-PPARγ signaling and remodeling of the gut microbiota. (2026/07/11) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. CYP450 network shifts in MASLD/MASH: from pathogenesis to nutrition-informed modulation. (2026/07/11) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Disulfiram Alleviates Metabolic Dysfunction-Associated Steatohepatitis in Mice via Inhibiting Aurora Kinase A and Restoring Autophagy. (2026/07/11) ♡
- Quantitative MR biomarkers in identifying steatohepatitis and fibrosis associated with metabolic dysfunction associated liver disease-a single center cross-sectional study. (2026/07/10) ♡
- Intestinal FXR deficiency uncouples steatosis protection from liver inflammation and fibrosis in MASH-diet fed mice. (2026/07/10) ♡
- Association between oxidative balance score and metabolic dysfunction-associated steatotic liver disease in US adolescents: A cross-sectional NHANES analysis. (2026/07/10) ♡
- Nonlinear association of remnant cholesterol inflammatory index with metabolic dysfunction-associated steatotic liver disease in US adults: A cross-sectional NHANES study. (2026/07/10) ♡
- Fucoxanthin Suppresses Lipid Accumulation and Inflammatory Responses in FFA-Induced Hepatocyte Models via the EGR2-CD36 Axis. (2026/07/10) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Addressing the Public Health Threat of Steatotic Liver Disease in Mexico. (2026/07/09) ♡
- PSMD2 mediates the degradation of CYP1A2 and promotes the progression of metabolic dysfunction-associated steatohepatitis. (2026/07/09) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Association Between Non-alcoholic Fatty Liver Disease and Subclinical Atherosclerosis Assessed by Carotid Intima-Media Thickness: A Systematic Review and Meta-Analysis. (2026/07/09) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Effect of weight loss interventions on liver-related health in children and adolescents with obesity: a systematic review and meta-analyses. (2026/07/08) ♡
- Cytokeratin-18 increase as a signal for early liver cell changes in high-fat diet-induced obesity before overt steatohepatitis. (2026/07/08) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Exercise-Induced Hepatic Mitochondrial Reprogramming Across Muscle-Gut-Thyroid Axes in MASLD/MASH. (2026/07/08) ♡
- Sonographic Grading of Non-alcoholic Fatty Liver Disease and Its Association With Serum Biomarkers, Echocardiography, and Electrocardiogram. (2026/07/08) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Atractylenolide I Alleviates Lipotoxicity in Hepatocytes and Protects NAFLD in Mice Through SIRT1-Dependent IRE1α-XBP1 Pathway. (2026/07/06) ♡
- Estradiol negatively associates with metabolic dysfunction-associated steatotic liver disease in children. (2026/07/06) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. From Weight Loss to Organ-Specific Disease Modification: A Narrative Review of Incretin-Based Therapies in Obesity-Related Cardiometabolic Disease, Chronic Kidney Disease, Metabolic Dysfunction-Associated Steatohepatitis, and Obstructive Sleep Apnoea. (2026/07/06) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Tao-Hong-Si-Wu-Tang protects against methionine- and choline-deficient diet-induced hepatic steatosis in rats and is associated with inhibition of oxidative stress, inflammation, apoptosis, and pyroptosis. (2026/07/06) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Transcriptomic Profiling Reveals Inflammatory, Fibrotic, and Apoptotic Signatures in a Methionine-Choline-Deficient Diet-Induced Murine Model of Metabolism-Dysfunction-Associated Steatohepatitis. (2026/07/05) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Comparative performance of insulin resistance-related indices in predicting adverse cardiovascular events among individuals with NAFLD and MASLD: a multi-center cohort study. (2026/07/04) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Hepatocyte Transforming Growth Factor-β-Oxyterol-Binding Protein Related 3 Signaling Axis Promotes Hepatic Stellate Cell Activation and Liver Fibrogenesis in Mice. (2026/07/03) ♡
- Ten-year prospective cohort study on the dynamic changes of metabolic syndrome and its determinants in the adult population of Iran. (2026/07/03) ♡
- Pistacia atlantica sub. Kurdica can improve insulin resistance in patients with non-alcoholic fatty liver disease: a randomized clinical trial. (2026/07/03) ♡
- Adipokine Profile in Non-alcoholic Fatty Liver Disease. (2026/07/03) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. A comprehensive compendium of berberine: sources, chemistry, and pharmacological activities. (2026/07/01) ♡
- Metabolite clusters linking fatty liver disease to cardiovascular mortality in coronary heart disease patients. (2026/07/01) ♡
- What screening approach could improve early detection of 'at-risk' metabolic dysfunction-associated steatohepatitis in my patients? (2026/07/01) ♡
- Adherence to UK Dietary Reference Values and Lower Odds of Non-Alcoholic Fatty Liver Disease: A Secondary Analysis of a Case-Control Study. (2026/07/01) ♡
- From Clinic to Community: A Public Health Framework for Metabolic Dysfunction-associated Steatotic Liver Disease Prevention in India. (2026/07/01) ♡
- Quzhou Fructus Aurantii extract alleviates metabolic dysfunction-associated steatohepatitis by activating the PPARα signaling pathway. (2026/07/01) ♡
- Association between dietary patterns and non-alcoholic fatty liver disease among adults from 15 provinces of China in 2015. (2026/07/01) ♡
- Evaluating the effect of γ-oryzanol on MASLD pathology using a medaka fish model. (2026/06/30) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Metabolic Dysfunction-Associated Fatty Liver Disease: From Pathogenesis to Treatment. (2026/06/30) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Intestinal neutral ceramidase, microbial metabolites and epithelial fucosylation in MASH. (2026/06/30) ♡
- Intestinal neutral ceramidase exacerbates MASH pathogenesis. (2026/06/30) ♡
- Terpenoid-enriched Curcuma wenyujin nanovesicles for suppressing inflammation and restoring lipid homeostasis in MASH. (2026/06/30) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Efficacy and Safety of Dual and Triple Glucagon-Like Peptide-1-Based Polyagonists in Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis: A Systematic Review and Meta-Analysis. (2026/06/29) ♡
- Diagnostic exogenous probe strategy using ezetimibe-glucuronide effectively identifies metabolic dysfunction-associated steatohepatitis. (2026/06/29) ♡
- Xiaoyaosan ameliorates stress-induced MASH via modulating IL-1R1/RXRα-mediated liver-brain crosstalk. (2026/06/28) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Herbal medicines modulate gut microbiota in metabolic diseases: a review. (2026/06/25) ♡
- Impaired Renal Mitochondria and Bioenergetics During Obesity-Associated NAFLD. (2026/06/24) ♡
- Rhein ameliorates MASH via EGFR/AKT/PPARα-mediated coordinated regulation of metabolism and inflammation. (2026/06/23) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Hepatoprotective effects of astaxanthin and kokum on lipid peroxidation and fatty acid profile in mice with diet-induced NAFLD. (2026/06/19) ♡
- Babaodan alleviates MAFLD through hepatic glycerophospholipid metabolism and PPARγ/RXRA/GPAT3 based on spatial metabolomics and proteomics analysis. (2026/06/12) ♡
- Yanxiao Di'naer decoction attenuates metabolic dysfunction-associated steatohepatitis through the regulation of gut microbiota and the metabolism of bile acid. (2026/06/12) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Multi-target mechanisms of Banxia Baizhu Tianma Decoction against MASH in a methionine-choline deficient mouse model: insights from a Multi-Omics Investigation. (2026/06/12) ♡
- Applicability of attenuation imaging and shear wave elastography in non-invasive assessment of liver steatosis and fibrosis in adult patients. (2026/06/03) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.